Your browser doesn't support javascript.
loading
Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway.
Liu, Yanlu; Gong, Shiting; Li, Kejian; Wu, Gong; Zheng, Xiaohong; Zheng, Jingna; Lu, Xiaowei; Zhang, Luyao; Li, Jincan; Su, Ziren; Liu, Yuhong; Xie, Jianhui; Chen, Jiannan; Li, Yucui.
Affiliation
  • Liu Y; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; School of Food & Pharmaceutical Engineering of Zhaoqing University, Zhaoqing 526040, China.
  • Gong S; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Dongguan Institute of Guangzhou University of Chinese Medicine, Dongguan 523808, China.
  • Li K; School of Basic Medical Sciences of Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Wu G; Department of TCM Orthopedics & Traumatology of Orthopedic Hospital of Longgang, Shenzhen 518000, China.
  • Zheng X; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Zheng J; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Lu X; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Zhang L; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Li J; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Su Z; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Liu Y; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Dongguan Institute of Guangzhou University of Chinese Medicine, Dongguan 523808, China.
  • Xie J; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Chen J; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Dongguan Institute of Guangzhou University of Chinese Medicine, Dongguan 523808, China. Electronic address: chenjiannan@gzucm.edu.cn.
  • Li Y; School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Dongguan Institute of Guangzhou University of Chinese Medicine, Dongguan 523808, China. Electronic address: liyucui@gzucm.edu.cn.
Biomed Pharmacother ; 156: 113941, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36411660
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hyperuricemia / Acute Kidney Injury Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biomed Pharmacother Year: 2022 Document type: Article Affiliation country: China Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hyperuricemia / Acute Kidney Injury Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biomed Pharmacother Year: 2022 Document type: Article Affiliation country: China Country of publication: France